Whitehawk Therapeutics, Inc.
WHWKNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $260.26M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.97$5.50
- Volume (live)
- -
- Avg. volume (3M)
- 350.85K
Whitehawk Therapeutics (WHWK) Stock Price & Financial Analysis
Whitehawk Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.08 - $3.22 |
|---|---|
| 52-Week High | $5.50 |
| 52-Week Low | $1.97 |
| Open | $3.21 |
| Volume (last close) | 235.78K |
| Average Volume (3M) | 350.85K |
| 50-Day MA | $4.09 |
|---|---|
| 200-Day MA | $3.81 |
| 1-Year Change | +32.65% |
| Market Cap | 260.26M |
|---|---|
| Shares Outstanding | 82.89M |
| Price to Book (P/B) | 1.42 |
| EV/EBITDA | -2.23 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Whitehawk Therapeutics at a Glance
As of the Oct 26, 2026 close, Whitehawk Therapeutics (WHWK) has a market capitalization of $260.26M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $85.23M in cash and securities against $0.00 of debt, a net cash position of $85.23M.
Whitehawk Therapeutics does not currently pay a dividend.
The share price is up 32.7% over the past year. At $3.14 (the Oct 26, 2026 close) it sits within its 52-week range of $1.97 to $5.50, below its 200-day moving average of $3.81.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $7.67, 144.3% above the Oct 26, 2026 close.
Frequently Asked Questions About Whitehawk Therapeutics
What is the current stock price for WHWK?
As of the Oct 26, 2026 close, WHWK stock trades at $3.14. The 52-week range is $1.97–$5.50, with a day range of $3.08–$3.22.
What is the P/E ratio for WHWK?
The P/E ratio (Price-to-Earnings) for WHWK is shown in the Key Statistics section. This valuation metric helps compare Whitehawk Therapeutics, Inc. to industry peers.
Does WHWK pay dividends?
Whitehawk Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for WHWK?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for WHWK is Buy. The average 12-month price target is $7.67, a 144.3% upside from the Oct 26, 2026 close of $3.14.
What is the market cap of WHWK?
As of the Oct 26, 2026 close, Whitehawk Therapeutics's market capitalization is $260.3M, classifying it as a micro-cap company. Whitehawk Therapeutics operates in the Healthcare sector within the Biotechnology industry.